Aurinia Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.55-$16.48 |
Market Cap | $2.1B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $265.8M |
Revenue Growth (YoY) | 8.4% |
Gross Profit (12 Mos) | $213M |
Diluted EPS | $0.56 |
News
See moreYahoo Finance • 26 days ago
Top FDA official Tidmarsh resigns after comments on kidney drug, HHS probe
Yahoo Finance • last month
Aurinia Pharmaceuticals Reaches Analyst Target Price
Yahoo Finance • last month
Xencor Stock Earns Relative Strength Rating Upgrade
Yahoo Finance • 2 months ago
Sector Update: Health Care Stocks Climb Late Afternoon
About
CEO | Mr. Peter S. Greenleaf M.B.A. |
Address | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
